Pharmacokinetics and Tolerability of Oral Semaglutide in Subjects with Renal Impairment

被引：0
|
作者：
Granhall, Charlotte
Rethy, Agnes
Sondergaard, Flemming L.
Thomsen, Mette
Anderson, Thomas W.
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1189-P
引用
收藏
页码：A317 / A318
页数：2
相关论文
共 50 条
  • [1] Pharmacokinetics and tolerability of oral semaglutide in subjects with renal impairment
    Anderson, T. W.
    Granhall, C.
    Rethy, A.
    Sondergaard, F. L.
    Thomsen, M.
    DIABETOLOGIA, 2017, 60 : S361 - S362
  • [2] Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
    Charlotte Granhall
    Flemming L. Søndergaard
    Mette Thomsen
    Thomas W. Anderson
    Clinical Pharmacokinetics, 2018, 57 : 1571 - 1580
  • [3] Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment
    Granhall, Charlotte
    Sondergaard, Flemming L.
    Thomsen, Mette
    Anderson, Thomas W.
    CLINICAL PHARMACOKINETICS, 2018, 57 (12) : 1571 - 1580
  • [4] Pharmacokinetics and tolerability of oral semaglutide in subjects with hepatic impairment
    Sondergaard, F. L.
    Baekdal, T. A.
    Kupcova, V.
    Thomsen, M.
    Anderson, T. W.
    DIABETOLOGIA, 2017, 60 : S362 - S362
  • [5] Pharmacokinetics and Tolerability of Oral Semaglutide in Subjects with Hepatic Impairment
    Thomsen, Mette
    Baekdal, Tine A.
    Kupcova, Viera
    Sonder-Gaard, Flemming L.
    Anderson, Thomas W.
    DIABETES, 2017, 66 : A318 - A318
  • [6] Pharmacokinetics, Safety, and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
    Baekdal, Tine A.
    Thomsen, Mette
    Kupcova, Viera
    Hansen, Cilie W.
    Anderson, Thomas W.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (10): : 1314 - 1323
  • [7] Pharmacokinetics and tolerability of semaglutide in subjects with hepatic impairment
    Arold, G.
    Kupcova, V.
    Jensen, L.
    Kvist, T.
    Pettersson, J.
    Hjerpsted, J.
    DIABETOLOGIA, 2017, 60 : S380 - S381
  • [8] Pharmacokinetics and tolerability of semaglutide in people with hepatic impairment
    Jensen, Lene
    Kupcova, Viera
    Arold, Gerhard
    Pettersson, Jonas
    Hjerpsted, Julie B.
    DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 998 - 1005
  • [9] Safety, Tolerability, and Pharmacokinetics of Single Escalating Doses of Oral Semaglutide in Healthy Male Subjects
    Baekdal, Tine A.
    Blicher, Thalia M.
    Donsmark, Morten
    Sondergaard, Flemming L.
    DIABETES, 2017, 66 : A318 - A318
  • [10] Erratum to: Abstracts of the 53rd Annual Meeting of the EASD, Lisbon 2017. Abstract 788: ‘Pharmacokinetics and tolerability of oral semaglutide in subjects with renal impairment’
    T. W. Anderson
    C. Granhall
    Á. Réthy
    F. L. Søndergaard
    M. Thomsen
    Diabetologia, 2017, 60 : 609 - 609
12345